Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
暂无分享，去创建一个
T. Merchant | P. Northcott | S. Pfister | A. Srinivasan | D. Ellison | R. Gilbertson | G. Neale | M. Chintagumpala | A. Mahajan | I. Buchhalter | A. Gajjar | B. Orr | U. Bartels | E. Bouffet | R. Cohn | F. Boop | J. Hansford | G. Robinson | C. Stewart | Kyle S. Smith | R. Tatevossian | G. McCowage | M. Fisher | A. Onar-Thomas | G. Wheeler | S. Gururangan | T. Hassall | M. Sullivan | M. Krasin | T. Lin | S. Kellie | A. Broniscer | T. Schechter | K. Schroeder | P. Klimo | W. Nicholls | T. Robertson | J. Su | Tong Lin